The oral-systemic personalized medicine model at Marshfield Clinic

Oral Diseases

Volumn 19, Issue 1, 2013, Pages 1-17

  Glurich, I ^a   Acharya, A ^b   Shukla, S K ^c   Nycz, G R ^c   Brilliant, M H ^c  

^a Office of Scientific Writing and Publication   (United States)

^b Biomedical Informatics Research Center   (United States)

^c MARSHFIELD CLINIC   (United States)

Author keywords

Diabetes; Periodontal disease; Personalized medicine

Indexed keywords

CXCL11 CHEMOKINE; GLUCOSE; HEMOGLOBIN A1C; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; STRESS ACTIVATED PROTEIN KINASE; STROMELYSIN 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

CLINICAL DECISION MAKING; CLINICAL RESEARCH; DECISION SUPPORT SYSTEM; DENTISTRY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; ELECTRONIC MEDICAL RECORD; GENE; HOSPITAL; HYPOTHESIS; INFORMATION SCIENCE; META ANALYSIS (TOPIC); METAGENOMICS; MICROBIOME; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PERIODONTAL DISEASE; PERIODONTITIS; PERSONALIZED MEDICINE; PHENOTYPE; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROCESS MODEL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STOMATOLOGY; SYSTEMATIC REVIEW (TOPIC);

DELIVERY OF HEALTH CARE, INTEGRATED; DENTAL INFORMATICS; DIABETES MELLITUS; HUMANS; INDIVIDUALIZED MEDICINE; MEDICAL INFORMATICS; METAGENOMICS; MICROBIOTA; PERIODONTAL DISEASES; UNITED STATES; WISCONSIN;

EID: 84870746585     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2012.01921.x     Document Type: Review

References (113)

1. Albandar JM, Brunelle JA, Kingman A (1999). Destructive periodontal disease in adults age 30years and older in the United States. J Periodontol70: 13-29.
2. American Dental Association Survey Center (2007). 2006 Technology survey. ADA: Chicago, IL, USA. Available at: http://www.ada.org/1440.aspx [accessed on 23 January 2012].
3. American Diabetes Association (2011). Diabetes statistics: data from the 2011 National diabetes fact sheet. American Diabetes Association. Available at: http://www.diabetes.org/diabetes-basics/diabetes-statistics/ [accessed on 24 January 2012].
4. Amir J, Waite M, Tobler J et al (2011). The role of hyperglycemia in mechanisms of exacerbated inflammatory responses within the oral cavity. Cell Immunol272: 45-52.
5. Araki E, Oyadomari S, Mori M (2003). Impact of endoplasmic reticulum stress pathway on pancreatic beta-cells and diabetes mellitus. Exp Biol Med (Maywood)228: 1213-1217.
6. Avila M, Ojcius DM, Yilmaz O (2009). The oral microbiota: living with a permanent guest. DNA Cell Biol28: 405-411.
7. Beck JD, Eke P, Heiss G et al (2005). Periodontal disease and coronary heart disease: a reappraisal of the exposure. Circulation112: 19-24.
8. Belting SM, Hiniker JJ, Dummett CO (1964). Influence of diabetes mellitus on severity of periodontal disease. J Periodontol35: 476-480.
9. Berbari EF, Cockerill FR III, Steckelberg JM (1997). Infective endocarditis due to unusual or fastidious microorganisms. Mayo Clin Proc72: 532-542.
10. Borrell LN, Papapanou PN (2005). Analytical epidemiology of periodontitis. J Clin Periodontol32: 132-158.
11. Brett PM, Zygogianni P, Griffiths GS et al (2005). Functional gene polymorphisms in aggressive and chronic periodontitis. J Dent Res84: 1149-1153.
12. Burt B, Research, Science and Therapy Committee of the American Academy of Periodontology (2005). Position paper: epidemiology of periodontal diseases. J Periodontol76: 1406-1419.
13. California Healthcare Foundation (2010). Health information technology in California dental practices: survey findings. California Healthcare Foundation. Available at: http://www.chcf.org/publications/2010/08/health-information-technology-in-california-dental-practices-survey-findings [accessed on 24 January 2012].
14. Centers for Disease Control and Prevention (2011). National diabetes fact sheet: fast facts on diabetes. US Department of Health and Human Services, Centers for Disease Control and Prevention: Atlanta, GA, USA. Available at: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf [accessed on 23 January 2012].
15. Chávarry NG, Vettore MV, Sansone C, Sheiham A (2009). The relationship between diabetes mellitus and destructive periodontal disease: a meta-analysis. Oral Health Prev Dent7: 107-127.
16. Chen T, Yu WH, Izard J, Baranova OV, Lakshmanan A, Dewhirst FE (2010). The Human Oral Microbiome Database: a web accessible resource for investigating oral microbe taxonomic and genomic information. Database (Oxford)2010: baq013.
17. Chi AC, Neville BW, Krayer JW, Gonsalves WC (2010). Oral manifestations of systemic disease. Am Fam Physician82: 1381-1388.
18. Colombo AP, Boches SK, Cotton SL et al (2009). Comparisons of subgingival microbial profiles of refractory periodontitis, severe periodontitis, and periodontal health using the human oral microbe identification microarray. J Periodontol80: 1421-1432.
19. Committee on Comparative Effectiveness Research Prioritization, Institute of Medicine (2009). Initial national priorities for comparative effectiveness research. National Academies Press: Washington, DC.
20. Committee on Quality of Health Care in America, Institute of Medicine (2001). Crossing the quality chasm: a new health system for the 21st century. National Academies Press: Washington, DC.
21. Committee on the Future of Dental Education; Field MJ, ed; Institute of Medicine (1995). Dental education at the crossroads: challenges and change. National Academies Press: Washington, DC.
22. Conway M, Berg RL, Carrell D et al (2011). Analyzing the heterogeneity and complexity of electronic health record oriented phenotyping algorithms. AMIA Annu Symp Proc2011: 274-283.
23. Covani U, Marconcini S, Derchi G, Barone A, Giacomelli L (2009). Relationship between human periodontitis and type 2 diabetes at a genomic level: a data-mining study. J Periodontol80: 1265-1273.
24. Darré L, Vergnes JN, Gourdy P, Sixou M (2008). Efficacy of periodontal treatment on glycaemic control in diabetic patients: a meta-analysis of interventional studies. Diabetes Metab34: 497-506.
25. Darveau RP (2010). Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol8: 481-490.
26. Deschner J, Haak T, Jepsen S et al (2011). Diabetes mellitus and periodontitis. Bidirectional relationship and clinical implications. A consensus document. Internist (Berl)52: 466-477.
27. Desvarieux M, Demmer RT, Jacobs DR Jr et al (2010). Periodontal bacteria and hypertension: the oral infections and vascular disease epidemiology study (INVEST). J Hypertens28: 1413-1421.
28. Dewhirst FE, Chen T, Izard J et al (2010). The human oral microbiome. J Bacteriol192: 5002-5017.
29. Dick RS, Steen EB, Detmer DE, eds, Committee on Improving the Patient Record, Institute of Medicine (1997). The computer-based patient record: an essential technology for health care. National Academies Press: Washington, DC.
30. Diehl SR, Wu T, Burmeister JA et al (2003). Evidence of a substantial genetic basis for IgG2 levels in families with aggressive periodontitis. J Dent Res82: 708-712.
31. Diehl SR, Wu T, Michalowicz BS et al (2005). Quantitative measures of aggressive periodontitis show substantial heritability and consistency with traditional diagnoses. J Periodontol76: 279-288.
32. Diehl SR, Chou CH, Kuo F, Huang CY (2011). Genetic factors and Periodontal Disease. In: Newman MG, Takei H, Carranza FA, Klokkevold PR, eds Carranza's clinical periodontology, 11th edn. Elsevier-Saunders: St. Louis, MO, USA, pp. 274-284.
33. Donath MY, Shoelson SE (2012). Type 2 diabetes as an inflammatory disease. Nat Rev Immunol11: 98-107.
34. Eng G, Chen A, Vess T, Ginsburg G (2012). Genome technologies and personalized dental medicine. Oral Dis18: 223-235.
35. Evans JL, Goldfine ID, Maddux BA, Grodsky GM (2003). Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?Diabetes52: 1-8.
36. Genco RJ, Grossi SG, Ho A, Nishimura F, Murayama Y (2005). A proposed model linking inflammation to obesity, diabetes, and periodontal infections. J Periodontol76: 2075-2084.
37. Ghebranious N, Mukesh B, Giampietro PF et al (2011). A pilot study of gene/gene and gene/environment interactions in Alzheimer disease. Clin Med Res9: 17-25.
38. Gordon JI, Ley RE, Wilson R et al (2005). Extending our view of self: the human gut microbiome initiative (HGMI). Available at: http://www.genome.gov/Pages/Research/Sequencing/SeqProposals/HGMISeq.pdf [accessed on 25 January 2012].
39. Huynh-Ba G, Lang NP, Tonetti MS, Salvi GE (2007). The association of the composite IL-1 genotype with periodontitis progression and/or treatment outcomes: a systematic review. J Clin Periodontol34: 305-317.
40. Jakubovics NS, Kolenbrander PE (2010). The road to ruin: the formation of disease-associated oral biofilms. Oral Dis16: 729-739.
41. Janket SJ, Wightman A, Baird AE, Van Dyke TE, Jones JA (2005). Does periodontal treatment improve glycemic control in diabetic patients? A meta-analysis of intervention studies. J Dent Res84: 1154-1159.
42. Jepsen S, Kebschull M, Deschner J (2011). Relationship between periodontitis and systemic diseases. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz54: 1089-1096.
43. Joshipura KJ, Hung HC, Rimm EB, Willett WC, Ascherio A (2003). Periodontal disease, tooth loss, and incidence of ischemic stroke. Stroke34: 47-52.
44. Kaur G, Holtfreter B, Rathmann W et al (2009). Association between type 1 and type 2 diabetes with periodontal disease and tooth loss. J Clin Periodontol36: 765-774.
45. Keavney B (2010). The interleukin 1 cluster, dyslipidemia and risk of myocardial infarction. BMC Med8: 6.
46. Kebschull M, Demmer RT, Papapanou PN (2010). "Gum bug, leave my heart alone!"- epidemiologic and mechanistic evidence linking periodontal infections and atherosclerosis. J Dent Res89: 879-902.
47. Keijser BJ, Zaura E, Huse SM et al (2008). Pyrosequencing analysis of the oral microflora of healthy adults. J Dent Res87: 1016-1020.
48. Khader YS, Dauod AS, El-Qaderi SS, Alkafajei A, Batayha WQ (2006). Periodontal status of diabetics compared with nondiabetics: a meta-analysis. J Diabetes Complications20: 59-68.
49. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N (2004). Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med141: 413-420.
50. Kim J, Amar S (2006). Periodontal disease and systemic conditions: a bidirectional relationship. Odontology94: 10-21.
51. Kinane DF, Hart TC (2003). Genes and gene polymorphisms associated with periodontal disease. Crit Rev Oral Biol Med14: 430-449.
52. Kinane D, Bouchard P, Group E of European Workshop on Periodontology (2008). Periodontal diseases and health: consensus report of the Sixth European Workshop on Periodontology. J Clin Periodontol35: 333-337.
53. King GL (2008). The role of inflammatory cytokines in diabetes and its complications. J Periodontol79: 1527-1534.
54. Kohn LT, Corrigan JM, Donaldson MS, eds, Committee on Quality of Health Care in America; Institute of Medicine (2000). To err is human: building a safer health system. National Academies Press: Washington, DC.
55. Kshirsagar AV, Moss KL, Elter JR, Beck JD, Offenbacher S, Falk RJ (2005). Periodontal disease is associated with renal insufficiency in the Atherosclerosis Risk In Communities (ARIC) study. Am J Kidney Dis45: 650-657.
56. Kuo LC, Polson AM, Kang T (2008). Associations between periodontal diseases and systemic diseases: a review of the inter-relationships and interactions with diabetes, respiratory diseases, cardiovascular diseases and osteoporosis. Public Health122: 417-433.
57. Laine ML, Loos BG, Crielaard W (2010). Gene polymorphisms in chronic periodontitis. Int J Dent2010: 324719.
58. Lalla E, Papapanou PN (2011). Diabetes mellitus and periodontitis: a tale of two common interrelated diseases. Nat Rev Endocrinol7: 738-748.
59. Lederberg J, Mccray AT (2001). Ome sweet omics - a genealogical treasury of words. Scientist15: 8-10.
60. Löe H (1993). Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care16: 329-334.
61. Loos BG (2005). Systemic markers of inflammation in periodontitis. J Periodontol76: 2106-2115.
62. Marigo L, Cerreto R, Giuliani M, Somma F, Lajolo C, Cordaro M (2011). Diabetes mellitus: biochemical, histological and microbiological aspects in periodontal disease. Eur Rev Med Pharmacol Sci15: 751-758.
63. McCarty CA, Chisholm RL, Chute CG et al (2011). The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics4: 13.
64. McCarty CA, Berg RL, Welter JD, Kitchner TE, Kemnitz JW (2012). A novel gene-environment interaction involved in endometriosis. Int J Gynaecol Obstet116: 61-63.
65. Mealey BL, Rose LF (2008). Diabetes mellitus and inflammatory periodontal diseases. Curr Opin Endocrinol Diabetes Obes15: 135-141.
66. Mealey BL, Oates TW, American Academy of Periodontology (2006). Diabetes mellitus and periodontal diseases. Periodontol77: 1289-1303.
67. Nagasawa T, Noda M, Katagiri S et al (2010). Relationship between periodontitis and diabetes - importance of a clinical study to prove the vicious cycle. Intern Med49: 881-885.
68. NIH HMP Working Group, Peterson J, Garges S et al (2009). The NIH Human Microbiome Project. Genome Res19: 2317-2323.
69. Nikolopoulos GK, Dimou NL, Hamodrakas SJ, Bagos PG (2008). Cytokine gene polymorphisms in periodontal disease: a meta-analysis of 53 studies including 4178 cases and 4590 controls. J Clin Periodontol35: 754-767.
70. O'Connor PJ, Sperl-Hillen J, Johnson PE, Rush WA, Crain AL (2009). Customized feedback to patients and providers failed to improve safety or quality of diabetes care: a randomized trial. Diabetes Care32: 1158-1163.
71. Offenbacher S, Beck JD, Lieff S, Slade G (1998). Role of periodontitis in systemic health: spontaneous preterm birth. J Dent Educ62: 852-858.
72. Offenbacher S, Barros SP, Paquette DW et al (2009). Gingival transcriptome patterns during induction and resolution of experimental gingivitis in humans. J Periodontol80: 1963-1982.
73. Onitilo AA, McCarty CA, Wilke RA et al (2009). Estrogen receptor genotype is associated with risk of venous thromboembolism during tamoxifen therapy. Breast Cancer Res Treat115: 643-650.
74. Osheroff JA, Teich JM, Middleton B, Steen EB, Wright A, Detmer DE (2007). A roadmap for national action on clinical decision support. J Am Med Inform Assoc14: 141-145.
75. Page RC, Eke PI (2007). Case definitions for use in population-based surveillance of periodontitis. J Periodontol78: 1387-1399.
76. Peterson KA, Radosevich DM, O'Connor PJ et al (2008). Improving diabetes care in practice: findings from the TRANSLATE trial. Diabetes Care31: 2238-2243.
77. Rajilić-Stojanović M, Smidt H, de Vos WM (2007). Diversity of the human gastrointestinal tract microbiota revisited. Environ Microbiol9: 2125-2136.
78. Reeser JC, Payne E, Kitchner T, McCarty CA (2011). Apolipoprotein e4 genotype increases the risk of being diagnosed with posttraumatic fibromyalgia. PM R3: 193-197.
79. Rial NS, Choi K, Nguyen T, Snyder B, Slepian MJ (2012). Nuclear factor kappa B (NF-κB): a novel cause for diabetes, coronary artery disease and cancer initiation and promotion?Med Hypotheses78: 29-32.
80. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS (1996). Evidence based medicine: what it is and what it isn't. BMJ312: 71-72.
81. Sakamoto M, Huang Y, Ohnishi M, Umeda M, Ishikawa I, Benno Y (2004). Changes in oral microbial profiles after periodontal treatment as determined by molecular analysis of 16S rRNA genes. J Med Microbiol53: 563-571.
82. Sakamoto M, Umeda M, Benno Y (2005). Molecular analysis of human oral microbiota. J Periodontal Res40: 277-285.
83. Santos Tunes R, Foss-Freitas MC, Nogueira-Filho Gda R (2010). Impact of periodontitis on the diabetes-related inflammatory status. J Can Dent Assoc76: a35.
84. Saremi A, Nelson RG, Tulloch-Reid M et al (2005). Periodontal disease and mortality in type 2 diabetes. Diabetes Care28: 27-32.
85. Satcher DS (2000). Surgeon General's report on oral health. Public Health Rep115: 489-490.
86. Savage A, Eaton KA, Moles DR, Needleman I (2009). A systematic review of definitions of periodontitis and methods that have been used to identify this disease. J Clin Periodontol36: 458-467.
87. Scannapieco FA (1999). Role of oral bacteria in respiratory infection. J Periodontol70: 793-802.
88. Schenkein HA (2002). Finding genetic risk factors for periodontal diseases: is the climb worth the view?Periodontol 200030: 79-90.
89. Schmittdiel J, McMenamin SB, Halpin HA et al (2004). The use of patient and physician reminders for preventive services: results from a National Study of Physician Organizations. Prev Med39: 1000-1006.
90. Seymour GJ, Ford PJ, Cullinan MP, Leishman S, Yamazaki K (2007). Relationship between periodontal infections and systemic disease. Clin Microbiol Infect13(Suppl 4): 3-10.
91. Shoelson SE, Lee J, Goldfine AB (2006). Inflammation and insulin resistance. J Clin Invest116: 1793-1801.
92. Shultis WA, Weil EJ, Looker HC et al (2007). Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes. Diabetes Care30: 306-311.
93. Simpson TC, Needleman I, Wild SH, Moles DR, Mills EJ (2010). Treatment of periodontal disease for glycaemic control in people with diabetes. Cochrane Database Syst Rev(15): CD004714.
94. Smyth S, Heron A (2006). Diabetes and obesity: the twin epidemics. Nat Med12: 75-80.
95. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr (1998). Microbial complexes in subgingival plaque. J Clin Periodontol25: 134-144.
96. Taylor GW (2001). Bidirectional interrelationships between diabetes and periodontal diseases: an epidemiologic perspective. Ann Periodontol6: 99-112.
97. Taylor GW, Borgnakke WS (2008). Periodontal disease: associations with diabetes, glycemic control and complications. Oral Dis14: 191-203.
98. Teeuw WJ, Gerdes VE, Loos BG (2010). Effect of periodontal treatment on glycemic control of diabetic patients: a systematic review and meta-analysis. Diabetes Care33: 421-427.
99. Thompson TG, Brailer DJ (2004). The decade of health information technology: delivering consumer-centric and information-rich health care - framework for strategic action. U.S. Department of Health and Human Services, Office of the National Coordinator for Health Information Technology: Washington, DC.
100. U.S. Department of Health and Human Services (2000). Oral health in America: a report of the surgeon general (executive summary). U.S. Department of Health and Human Services, National Institute of Dental and Craniofacial Research, National Institutes of Health: Rockville, MD, USA. Available at: http://silk.nih.gov/public/hck1ocv.@www.surgeon.fullrpt.pdf [accessed on 24 January 2012].
101. Wade WG (2011). Has the use of molecular methods for the characterization of the human oral microbiome changed our understanding of the role of bacteria in the pathogenesis of periodontal disease?J Clin Periodontol38: 7-16.
102. Waudby CJ, Berg RL, Linneman JG et al (2011). Cataract research using electronic health records. BMC Ophthalmol11: 32.
103. Weidlich P, Cimões R, Pannuti CM, Oppermann RV (2008). Association between periodontal diseases and systemic diseases. Braz Oral Res22(Suppl 1): 32-43.
104. White JM, Kalenderian E, Stark PC, Ramoni RL, Vaderhobli R, Walji MF (2011). Evaluating a dental diagnostic terminology in an electronic health record. J Dent Educ75: 605-615.
105. Wilke RA, Berg RL, Peissig P et al (2007). Use of an electronic medical record for the identification of research subjects with diabetes mellitus. Clin Med Res5: 1-7.
106. Wilke RA, Berg RL, Linneman JG, Zhao C, McCarty CA, Krauss RM (2008). Characterization of low-density lipoprotein cholesterol-lowering efficacy for atorvastatin in a population-based DNA biorepository. Basic Clin Pharmacol Toxicol103: 354-359.
107. Wilke RA, Simpson RU, Mukesh BN et al (2009). Genetic variation in CYP27B1 is associated with congestive heart failure in patients with hypertension. Pharmacogenomics10: 1789-1797.
108. Wilke RA, Berg RL, Linneman JG et al (2010). Quantification of the clinical modifiers impacting high-density lipoprotein cholesterol in the community: personalized Medicine Research Project. Prev Cardiol13: 63-68.
109. Williams RC, Barnett AH, Claffey N et al (2008). The potential impact of periodontal disease on general health: a consensus view. Curr Med Res Opin24: 1635-1643.
110. World Health Organization (2009). Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. World Health Organization: Geneva, Switzerland.
111. Xie G, Chain PS, Lo CC et al (2010). Community and gene composition of a human dental plaque microbiota obtained by metagenomic sequencing. Mol Oral Microbiol25: 391-405.
112. Yazigi N, Yale S, Caldwell M et al (2010). Modeling clearance of warfarin. J Gen Intern Med25(Suppl 3): S334. (Abstract)
113. Zarco M, Vess T, Ginsburg G (2012). The oral microbiome in health and disease and the potential impact on personalized dental health. Oral Dis18: 109-120.